Gyeyoung Choi

Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: Phase 3, randomized, vehicle-controlled study (CAPTAIN-AD)

Chun Wook Park, Beom Joon Kim, Yang Won Lee et al. · Journal of Allergy and Clinical Immunology · 2021 · 90 citations · Full text

Medicine, Dermatology, Pharmacology +11

Efficacy and safety of<scp>PAC</scp>‐14028 cream – a novel, topical, nonsteroidal, selective<scp>TRPV</scp>1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a phase<scp>II</scp>b randomized trial

Y.W. Lee, Chong Hyun Won, Kyoung-Mi Jung et al. · British Journal of Dermatology · 2019 · 86 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy

Gyeyoung Choi, Gyeongseon Shin, SeungJin Bae · International Journal of Environmental Research and Public Health · 2022 · 78 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Compound K inhibits MMP‐1 expression through suppression of c‐Src‐dependent ERK activation in TNF‐α‐stimulated dermal fibroblast

Chang Seok Lee, Il‐Hong Bae, Jiwon Han et al. · Experimental Dermatology · 2014 · 36 citations

Life Sciences, Cell Biology, Pharmacology +16

Retinoic acid alleviates <scp>C</scp>on <scp>A</scp>‐induced hepatitis and differentially regulates effector production in <scp>NKT</scp> cells

Kyoo‐A Lee, You Chan Song, Ga‐Young Kim et al. · European Journal of Immunology · 2012 · 29 citations · Full text

Life Sciences, Immunology, Pathology +17